Nuvonis is providing GMP Master and Working Cell Banks for vaccine development and production to our clients. Fully characterized MCB and WCB banks including tumorigenicity testing at the end of production level (EOP). Our cell banks can be used as growth substrate for a variety of viruses applied in modern vaccine development. The NUVONIS team is also highly experienced in the development and optimization of up- and downstream vaccine production processes.
R&D:Research focus is on development of new and innovative Vero suspension cell lines, Avian cell lines and purification approaches.
Mariahilfer Straße 101/1/21
1060 Vienna
Vienna
Contact: Michael Tscheppe
Email: office@nuvonis.com
Website